A Population-Based Assessment of Myocarditis Following mRNA COVID-19 booster Vaccination Among Adult Recipients
Description
CONCLUSION: Myocarditis following mRNA COVID-19 vaccines is a rare event. A lower absolute risk of myocarditis was observed following a booster dose of mRNA vaccine compared to the primary series second dose.
